(ETON) Eton Pharmaceuticals - Performance 368.6% in 12m
Compare ETON with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
45.40%
#23 in Group
Rel. Strength
99.61%
#32 in Universe
Total Return 12m
368.63%
#1 in Group
Total Return 5y
239.81%
#10 in Group
P/E -
(?) Percentile in Group
P/E Forward 28.2
71th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 0.37%
42th Percentile in Group
12m Total Return: ETON (368.6%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: ETON vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ETON
Total Return (including Dividends) | ETON | XLV | S&P 500 |
---|---|---|---|
1 Month | -2.32% | -7.37% | -5.89% |
3 Months | -6.09% | -4.55% | -12.45% |
12 Months | 368.63% | -0.54% | 6.72% |
5 Years | 239.81% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | ETON | XLV | S&P 500 |
1 Month | -27.1% | -82.6% | -74.5% |
3 Months | -79.1% | -37.8% | -88.2% |
12 Months | 92.2% | -1.6% | 66.1% |
5 Years | -14.4% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #46 | 5.46% | 3.79% |
3 Month | #60 | -1.61% | 7.26% |
12 Month | #1 | 371% | 339% |
5 Years | #10 | 132% | 69.0% |
FAQs
Does ETON Eton Pharmaceuticals outperforms the market?
Yes,
over the last 12 months ETON made 368.63%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months ETON made -6.09%, while XLV made -4.55%.
Over the last 3 months ETON made -6.09%, while XLV made -4.55%.
Performance Comparison ETON vs Indeces and Sectors
ETON vs. Indices ETON is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 16.6% | 3.57% | 81.1% | 362% |
US NASDAQ 100 | QQQ | 17.5% | 3.96% | 81.7% | 363% |
US Dow Jones Industrial 30 | DIA | 17.8% | 3.50% | 80.6% | 363% |
German DAX 40 | DAX | 11.2% | 7.08% | 64.1% | 350% |
Shanghai Shenzhen CSI 300 | CSI 300 | 15.9% | 5.18% | 78.8% | 363% |
Hongkong Hang Seng | HSI | 12.3% | 7.50% | 79.6% | 352% |
India NIFTY 50 | INDA | 12.2% | -7.09% | 78.7% | 366% |
Brasil Bovespa | EWZ | 13.0% | 2.76% | 78.2% | 378% |
ETON vs. Sectors ETON is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 16.3% | 3.34% | 72.3% | 355% |
Consumer Discretionary | XLY | 17.5% | 1.60% | 78.4% | 359% |
Consumer Staples | XLP | 13.3% | -5.52% | 70.9% | 355% |
Energy | XLE | 11.9% | 7.76% | 80.1% | 379% |
Financial | XLF | 15.2% | 2.19% | 73.0% | 350% |
Health Care | XLV | 16.2% | 5.05% | 82.5% | 369% |
Industrial | XLI | 15.5% | 2.38% | 81.0% | 363% |
Materials | XLB | 14.9% | 4.33% | 88.2% | 376% |
Real Estate | XLRE | 11.3% | 0.57% | 79.8% | 352% |
Technology | XLK | 18.0% | 6.61% | 87.9% | 370% |
Utilities | XLU | 13.3% | -1.90% | 75.4% | 344% |
Aerospace & Defense | XAR | 14.9% | -2.36% | 71.4% | 344% |
Biotech | XBI | 13.0% | 9.56% | 95.7% | 378% |
Homebuilder | XHB | 15.6% | 4.52% | 99.0% | 378% |
Retail | XRT | 14.9% | -0.21% | 85.8% | 373% |